CSL Limited Logo

CSL Limited

CSL.AX

(2.0)
Stock Price

294,48 AUD

16.76% ROA

15.58% ROE

28.66x PER

Market Cap.

94.230.126.372,10 AUD

77.45% DER

1.86% Yield

17.96% NPM

CSL Limited Stock Analysis

CSL Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CSL Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (19.11%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROA

The stock's ROA (8.53%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 DER

The stock maintains a fair debt to equity ratio (66%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (921) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (5.41x) suggests it's overvalued, potentially making it an expensive investment.

8 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

CSL Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CSL Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

CSL Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CSL Limited Revenue
Year Revenue Growth
1992 167.696.000
1993 192.996.000 13.11%
1994 250.430.000 22.93%
1995 281.102.016 10.91%
1996 318.098.008 11.63%
1997 0 0%
1998 0 0%
1999 0 0%
2000 843.308.000 100%
2001 756.585.970 -11.46%
2002 878.656.712 13.89%
2003 1.156.636.673 24.03%
2004 2.096.817.336 44.84%
2005 2.114.029.177 0.81%
2006 2.690.752.332 21.43%
2007 3.402.820.486 20.93%
2008 3.730.499.241 8.78%
2009 3.786.870.352 1.49%
2010 4.475.508.197 15.39%
2011 4.536.913.851 1.35%
2012 4.950.400.000 8.35%
2013 5.334.800.000 7.21%
2014 5.458.600.000 2.27%
2015 5.909.500.000 7.63%
2016 6.615.800.000 10.68%
2017 7.587.900.000 12.81%
2018 8.509.900.000 10.83%
2019 9.100.500.000 6.49%
2020 13.260.236.048 31.37%
2020 10.265.300.000 -29.18%
2021 10.493.100.000 2.17%
2022 18.396.654.200 42.96%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CSL Limited Research and Development Expenses
Year Research and Development Expenses Growth
1992 18.981.000
1993 24.004.000 20.93%
1994 27.097.000 11.41%
1995 30.197.000 10.27%
1996 36.566.000 17.42%
1997 0 0%
1998 0 0%
1999 0 0%
2000 81.208.000 100%
2001 52.514.919 -54.64%
2002 61.672.237 14.85%
2003 70.745.503 12.83%
2004 111.111.874 36.33%
2005 119.486.947 7.01%
2006 161.871.077 26.18%
2007 215.383.511 24.85%
2008 251.489.008 14.36%
2009 269.172.651 6.57%
2010 347.504.435 22.54%
2011 363.305.156 4.35%
2012 426.800.000 14.88%
2013 466.400.000 8.49%
2014 462.700.000 -0.8%
2015 613.800.000 24.62%
2016 645.300.000 4.88%
2017 702.400.000 8.13%
2018 831.800.000 15.56%
2019 921.800.000 9.76%
2020 1.343.144.397 31.37%
2020 1.001.400.000 -34.13%
2021 1.156.200.000 13.39%
2022 1.977.343.800 41.53%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CSL Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1992 11.871.000
1993 0 0%
1994 0 0%
1995 0 0%
1996 2.359.000 100%
1997 0 0%
1998 0 0%
1999 0 0%
2000 90.190.000 100%
2001 57.589.235 -56.61%
2002 62.073.822 7.22%
2003 91.608.812 32.24%
2004 133.119.072 31.18%
2005 363.390.273 63.37%
2006 162.954.198 -123%
2007 240.763.100 32.32%
2008 328.682.571 26.75%
2009 202.575.957 -62.25%
2010 229.632.559 11.78%
2011 235.892.503 2.65%
2012 280.000.000 15.75%
2013 291.600.000 3.98%
2014 287.500.000 -1.43%
2015 408.300.000 29.59%
2016 484.800.000 15.78%
2017 514.800.000 5.83%
2018 574.800.000 10.44%
2019 691.800.000 16.91%
2020 1.008.013.988 31.37%
2020 731.700.000 -37.76%
2021 688.000.000 -6.35%
2022 1.508.306.440 54.39%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CSL Limited EBITDA
Year EBITDA Growth
1992 21.007.208
1993 24.351.321 13.73%
1994 44.636.909 45.45%
1995 58.358.533 23.51%
1996 39.665.099 -47.13%
1997 40.710.690 2.57%
1998 47.395.896 14.11%
1999 68.226.760 30.53%
2000 69.006.904 1.13%
2001 170.614.796 59.55%
2002 172.328.383 0.99%
2003 285.508.736 39.64%
2004 650.844.085 56.13%
2005 243.113.786 -167.71%
2006 778.791.349 68.78%
2007 1.094.152.371 28.82%
2008 1.289.173.419 15.13%
2009 1.320.891.514 2.4%
2010 1.473.496.783 10.36%
2011 1.460.793.745 -0.87%
2012 1.716.700.000 14.91%
2013 1.852.200.000 7.32%
2014 1.954.900.000 5.25%
2015 1.847.800.000 -5.8%
2016 1.941.200.000 4.81%
2017 2.686.300.000 27.74%
2018 2.893.200.000 7.15%
2019 3.143.300.000 7.96%
2020 3.968.381.174 20.79%
2020 3.629.200.000 -9.35%
2021 3.464.900.000 -4.74%
2022 3.831.873.080 9.58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CSL Limited Gross Profit
Year Gross Profit Growth
1992 167.696.000
1993 192.996.000 13.11%
1994 250.430.000 22.93%
1995 281.102.016 10.91%
1996 318.098.008 11.63%
1997 0 0%
1998 0 0%
1999 0 0%
2000 369.309.000 100%
2001 297.945.614 -23.95%
2002 326.115.813 8.64%
2003 408.527.522 20.17%
2004 810.655.138 49.61%
2005 850.295.335 4.66%
2006 1.217.009.330 30.13%
2007 1.557.561.638 21.86%
2008 1.793.804.274 13.17%
2009 1.930.031.020 7.06%
2010 2.200.244.747 12.28%
2011 2.189.553.186 -0.49%
2012 2.559.000.000 14.44%
2013 2.730.800.000 6.29%
2014 2.852.700.000 4.27%
2015 2.874.700.000 0.77%
2016 3.289.000.000 12.6%
2017 4.056.300.000 18.92%
2018 4.748.700.000 14.58%
2019 5.176.100.000 8.26%
2020 7.542.037.010 31.37%
2020 5.798.600.000 -30.07%
2021 5.663.500.000 -2.39%
2022 8.950.746.240 36.73%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CSL Limited Net Profit
Year Net Profit Growth
1992 9.245.763
1993 8.038 -114939.98%
1994 -4.971 261.68%
1995 0 0%
1996 26.490.625 100%
1997 27.845.272 4.86%
1998 31.629.751 11.96%
1999 32.480.745 2.62%
2000 39.926.415 18.65%
2001 69.703.862 42.72%
2002 47.451.015 -46.9%
2003 153.550.629 69.1%
2004 416.718.516 63.15%
2005 87.084.638 -378.52%
2006 457.420.696 80.96%
2007 671.445.930 31.88%
2008 924.824.870 27.4%
2009 894.829.389 -3.35%
2010 1.005.280.764 10.99%
2011 1.005.587.736 0.03%
2012 1.216.300.000 17.32%
2013 1.307.000.000 6.94%
2014 1.379.000.000 5.22%
2015 1.242.400.000 -10.99%
2016 1.337.400.000 7.1%
2017 1.728.900.000 22.64%
2018 1.918.700.000 9.89%
2019 2.102.500.000 8.74%
2020 3.063.529.069 31.37%
2020 2.375.000.000 -28.99%
2021 2.254.700.000 -5.34%
2022 1.713.998.240 -31.55%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CSL Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1992 0
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 1 0%
2005 0 0%
2006 1 0%
2007 1 100%
2008 2 0%
2009 2 0%
2010 2 0%
2011 2 0%
2012 2 50%
2013 3 0%
2014 3 0%
2015 3 0%
2016 3 0%
2017 4 33.33%
2018 4 25%
2019 5 0%
2020 7 33.33%
2020 5 -20%
2021 5 -25%
2022 4 -33.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CSL Limited Free Cashflow
Year Free Cashflow Growth
1992 -16.634.216
1993 2.004.042 930.03%
1994 19.099.615 89.51%
1995 44.200.509 56.79%
1996 45.331.878 2.5%
1997 14.708.566 -208.2%
1998 5.580.700 -163.56%
1999 30.213.744 81.53%
2000 97.956.112 69.16%
2001 83.435.411 -17.4%
2002 53.623.022 -55.6%
2003 145.668.833 63.19%
2004 480.885.104 69.71%
2005 425.242.761 -13.08%
2006 -176.335.573 341.16%
2007 481.254.811 136.64%
2008 768.260.259 37.36%
2009 916.748.491 16.2%
2010 791.316.529 -15.85%
2011 841.826.555 6%
2012 964.131.806 12.69%
2013 1.042.579.830 7.52%
2014 1.361.720.833 23.44%
2015 1.021.426.313 -33.32%
2016 760.044.826 -34.39%
2017 1.033.000.000 26.42%
2018 1.057.483.360 2.32%
2019 2.237.946.700 52.75%
2020 3.163.065.840 29.25%
2021 2.560.143.600 -23.55%
2022 722.473.680 -254.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CSL Limited Operating Cashflow
Year Operating Cashflow Growth
1992 14.578.000
1993 38.371.000 62.01%
1994 41.368.000 7.24%
1995 56.972.984 27.39%
1996 57.859.008 1.53%
1997 27.845.272 -107.79%
1998 31.629.751 11.96%
1999 52.405.517 39.64%
2000 129.038.000 59.39%
2001 130.085.000 0.8%
2002 128.169.555 -1.49%
2003 206.994.000 38.08%
2004 567.822.000 63.55%
2005 522.164.000 -8.74%
2006 480.840.000 -8.59%
2007 715.336.000 32.78%
2008 1.024.824.000 30.2%
2009 1.168.492.000 12.3%
2010 1.018.119.000 -14.77%
2011 1.160.000.000 12.23%
2012 1.414.231.806 17.98%
2013 1.444.479.830 2.09%
2014 1.775.520.833 18.64%
2015 1.587.126.313 -11.87%
2016 1.620.644.826 2.07%
2017 2.025.600.000 19.99%
2018 2.342.283.360 13.52%
2019 3.605.546.700 35.04%
2020 4.830.165.840 25.35%
2021 3.807.843.600 -26.85%
2022 1.216.509.350 -213.01%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CSL Limited Capital Expenditure
Year Capital Expenditure Growth
1992 31.212.216
1993 36.366.958 14.17%
1994 22.268.385 -63.31%
1995 12.772.475 -74.35%
1996 12.527.130 -1.96%
1997 13.136.706 4.64%
1998 26.049.051 49.57%
1999 22.191.773 -17.38%
2000 31.081.888 28.6%
2001 46.649.589 33.37%
2002 74.546.533 37.42%
2003 61.325.167 -21.56%
2004 86.936.896 29.46%
2005 96.921.239 10.3%
2006 657.175.573 85.25%
2007 234.081.189 -180.75%
2008 256.563.741 8.76%
2009 251.743.509 -1.91%
2010 226.802.471 -11%
2011 318.173.445 28.72%
2012 450.100.000 29.31%
2013 401.900.000 -11.99%
2014 413.800.000 2.88%
2015 565.700.000 26.85%
2016 860.600.000 34.27%
2017 992.600.000 13.3%
2018 1.284.800.000 22.74%
2019 1.367.600.000 6.05%
2020 1.667.100.000 17.97%
2021 1.247.700.000 -33.61%
2022 494.035.670 -152.55%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CSL Limited Equity
Year Equity Growth
1992 104.760.155
1993 231.327.317 54.71%
1994 235.253.009 1.67%
1995 268.975.619 12.54%
1996 273.590.764 1.69%
1997 242.273.859 -12.93%
1998 276.980.275 12.53%
1999 473.807.391 41.54%
2000 447.001.730 -6%
2001 716.772.323 37.64%
2002 864.281.864 17.07%
2003 1.450.064.671 40.4%
2004 1.581.809.864 8.33%
2005 1.476.531.960 -7.13%
2006 1.924.384.224 23.27%
2007 2.684.747.563 28.32%
2008 4.408.831.552 39.11%
2009 3.582.368.589 -23.07%
2010 3.894.961.845 8.03%
2011 3.508.504.411 -11.01%
2012 3.006.800.000 -16.69%
2013 3.162.000.000 4.91%
2014 2.746.900.000 -15.11%
2015 2.567.200.000 -7%
2016 3.163.800.000 18.86%
2017 4.079.900.000 22.45%
2018 5.251.300.000 22.31%
2019 6.527.400.000 19.55%
2020 8.381.300.000 22.12%
2021 14.577.500.000 42.51%
2022 17.826.000.000 18.22%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CSL Limited Assets
Year Assets Growth
1992 153.075.130
1993 312.671.806 51.04%
1994 335.456.127 6.79%
1995 373.815.593 10.26%
1996 385.179.653 2.95%
1997 325.150.388 -18.46%
1998 374.853.468 13.26%
1999 565.095.827 33.67%
2000 904.155.376 37.5%
2001 1.301.723.905 30.54%
2002 1.495.524.621 12.96%
2003 2.709.470.674 44.8%
2004 2.954.140.361 8.28%
2005 3.106.279.960 4.9%
2006 3.562.081.425 12.8%
2007 4.491.885.841 20.7%
2008 5.945.390.935 24.45%
2009 4.853.647.219 -22.49%
2010 5.416.494.239 10.39%
2011 5.955.441.390 9.05%
2012 5.975.500.000 0.34%
2013 6.277.700.000 4.81%
2014 6.401.000.000 1.93%
2015 7.562.700.000 15.36%
2016 9.122.700.000 17.1%
2017 10.774.500.000 15.33%
2018 12.314.400.000 12.5%
2019 15.464.600.000 20.37%
2020 18.156.900.000 14.83%
2021 28.346.000.000 35.95%
2022 36.234.000.000 21.77%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CSL Limited Liabilities
Year Liabilities Growth
1992 48.314.975
1993 81.349.604 40.61%
1994 100.203.118 18.82%
1995 104.839.980 4.42%
1996 111.588.895 6.05%
1997 82.876.529 -34.64%
1998 97.873.193 15.32%
1999 91.288.435 -7.21%
2000 457.153.646 80.03%
2001 584.951.582 21.85%
2002 631.242.757 7.33%
2003 1.259.406.003 49.88%
2004 1.372.330.497 8.23%
2005 1.629.748.000 15.79%
2006 1.637.697.201 0.49%
2007 1.807.138.278 9.38%
2008 1.536.559.383 -17.61%
2009 1.271.278.630 -20.87%
2010 1.521.532.394 16.45%
2011 2.446.936.979 37.82%
2012 2.968.700.000 17.58%
2013 3.115.700.000 4.72%
2014 3.654.100.000 14.73%
2015 4.995.500.000 26.85%
2016 5.958.900.000 16.17%
2017 6.694.600.000 10.99%
2018 7.063.100.000 5.22%
2019 8.937.200.000 20.97%
2020 9.775.600.000 8.58%
2021 13.768.500.000 29%
2022 18.408.000.000 25.2%

CSL Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
41.19
Net Income per Share
6.8
Price to Earning Ratio
28.66x
Price To Sales Ratio
4.69x
POCF Ratio
24.28
PFCF Ratio
45.64
Price to Book Ratio
6.02
EV to Sales
5.23
EV Over EBITDA
17.92
EV to Operating CashFlow
26.8
EV to FreeCashFlow
50.81
Earnings Yield
0.03
FreeCashFlow Yield
0.02
Market Cap
94,23 Bil.
Enterprise Value
104,91 Bil.
Graham Number
70.42
Graham NetNet
-26.05

Income Statement Metrics

Net Income per Share
6.8
Income Quality
1.18
ROE
0.13
Return On Assets
0.07
Return On Capital Employed
0.11
Net Income per EBT
0.81
EBT Per Ebit
0.9
Ebit per Revenue
0.24
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0.09
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.48
Operating Profit Margin
0.24
Pretax Profit Margin
0.22
Net Profit Margin
0.18

Dividends

Dividend Yield
0.02
Dividend Yield %
1.86
Payout Ratio
0.49
Dividend Per Share
3.63

Operating Metrics

Operating Cashflow per Share
8.03
Free CashFlow per Share
4.24
Capex to Operating CashFlow
-0.47
Capex to Revenue
-0.09
Capex to Depreciation
-1.69
Return on Invested Capital
0.14
Return on Tangible Assets
0.17
Days Sales Outstanding
34.64
Days Payables Outstanding
30.7
Days of Inventory on Hand
204.66
Receivables Turnover
10.54
Payables Turnover
11.89
Inventory Turnover
1.78
Capex per Share
-3.8

Balance Sheet

Cash per Share
3,18
Book Value per Share
32,39
Tangible Book Value per Share
2.83
Shareholders Equity per Share
32.39
Interest Debt per Share
26.24
Debt to Equity
0.77
Debt to Assets
0.34
Net Debt to EBITDA
1.82
Current Ratio
2.01
Tangible Asset Value
1,38 Bil.
Net Current Asset Value
-9,15 Bil.
Invested Capital
0.77
Working Capital
4,65 Bil.
Intangibles to Total Assets
0.45
Average Receivables
0,95 Bil.
Average Payables
1,02 Bil.
Average Inventory
6821021400
Debt to Market Cap
0.13

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CSL Limited Dividends
Year Dividends Growth
1994 0
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 1 0%
2007 1 100%
2008 0 0%
2009 1 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 100%
2014 1 0%
2015 2 0%
2016 2 0%
2017 2 0%
2018 2 50%
2019 3 0%
2020 3 0%
2021 3 0%
2022 3 33.33%
2023 2 -200%

CSL Limited Profile

About CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

CEO
Dr. Paul F. McKenzie Ph.D.
Employee
32.065
Address
45 Poplar Road
Parkville, 3052

CSL Limited Executives & BODs

CSL Limited Executives & BODs
# Name Age
1 Dr. Paul F. McKenzie Ph.D.
MD, Chief Executive Officer & Executive Director
70
2 Dr. Karen Etchberger
Executive Vice President of Quality & Business Services
70
3 Ms. Roanne Parry
Chief Human Resources Officer
70
4 Mr. Gregory Boss B.S., BS(Hons), J.D.
Executive Vice President of Legal & General Counsel
70
5 Christina Hickie
Senior Manager of Communications
70
6 Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D.
Senior Vice President of Research
70
7 Dr. William Mezzanotte M.D., M.P.H.
Executive Vice President & Head of Research and Development
70
8 Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI
Chief Financial Officer
70
9 Mr. Mark Dehring
Head of Investor Relations
70
10 Ms. Jemimah Brennan
Head of Communications - Asia Pacific
70

CSL Limited Competitors

Cochlear Limited Logo
Cochlear Limited

COH.AX

(2.5)
Wesfarmers Limited Logo
Wesfarmers Limited

WES.AX

(2.0)
Rio Tinto Group Logo
Rio Tinto Group

RIO.AX

(2.8)